当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

A Novel Oxidative Stress-Responsive Apoptosis Inducing Protein (ORAIP) may have Possible Effects on Immune Disorders

Yoshinori Seko

We previously identified a novel apoptosis inducing humoral factor in the conditioned medium of hypoxic/ reoxygenated cardiac myocytes. Myocardial ischemia/reperfusion markedly increased plasma ORAIP levels and myocardial ischemia/reperfusion injury was clearly suppressed by neutralizing anti-ORAIP antibodies in vivo. We named this novel post-translationally modified secreted-form of eukaryotic translation initiation factor 5A, as Oxidative Stress-Responsive Apoptosis Inducing Protein (ORAIP). Evidence has accumulated that ORAIP may be a common and the dominant apoptosis-inducer among various cell types in response to various types of oxidative stress involved in a wide spectrum of acute and chronic disorders. We found infiltrating immune cells strongly expressed ORAIP in the tissues with myocarditis, aortitis, and atherosclerosis, suggesting that ORAIP-mediated apoptotic signalling may play a role in the pathogenesis involved. Further investigation is needed to confirm whether ORAIP can be a sensitive biomarker and a therapeutic target for the cell injury involved in immune disorders.